Review
Sep 2026
CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.
Incretin-based therapies have evolved from selective GLP-1RA to dual GLP-1/ GIP agonists and unimolecular triple GLP-1/GIP/glucagon receptor agonists. This review examines the cardiovascular effects of these three pharmacological tiers, with emphasis on mechanisms that operate beyond glycaemic control. Mediation analys...
M. Ravić, I. Srejović, I. Milosavljević et al.
· Canadian Journal of Physiolo... · 0 citations